Suplementos nutricionais no Transtorno do Espectro Autista: um relato de caso
Article Sidebar
Main Article Content
Abstract
Introduction: Studies have shown that the use of nutritional supplements can bring great benefits in reducing the symptoms of Autism Spectrum Disorder (ASD). In addition, it is known that the drugs approved for use in the treatment of ASD provide partial relief of symptoms and can cause physical and/or psychological dependence, in addition to important adverse reactions. Objectives: To report the benefits of prescribing supplements for a pediatric patient with ASD, during an intervention performed by a pharmacist. Methods: After parental consent, the data recorded in the health facility's system were analyzed. The data presented refer to the period from October 2021 to March 2022. The main data analyzed were: diagnosis, symptoms, therapeutic comorbidities and treatments performed. Results: The selected case refers to a 10-year-old patient with severe ASD for 8 years. In pharmaceutical care, the main interventions were: guidance on the use of medications and prescription of supplements, such as vitamins, amino acids, fats, minerals and antioxidants. The main benefits observed were: improvement in cognition, social interaction and sensitivity to light; reduced irritability, inspiration, constipation; improved sleep and speech development. For this evaluation, instruments such as the ATEC tool and reports from the person responsible for the patient were used. Conclusion: ASD supplementation can improve symptoms such as gastrointestinal disorders, sleep disorders and cognitive functions. In this case report, the patient showed improvement in symptoms after pharmaceutical intervention with the prescription of compounded formulas.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
• The author (s) warrant that the contribution is original and unpublished and that it is not in the process of being evaluated in other journal (s);
• The journal is not responsible for the opinions, ideas and concepts issued in the texts, as they are the sole responsibility of the author (s);
• Publishers have the right to make textual adjustments and to adapt the article to the rules of publication.
Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg publish in institutional repository or as book chapter), with acknowledgment of authorship and initial publication in this journal.
Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and citation of the published work (See The Effect of Free Access) at http://opcit.eprints.org/oacitation-biblio.html
References
ADAMS, Jb; AUDHYA, T; GEIS, E; GEHN, E; FIMBRES, V; POLLARD, El; MITCHELL, J; INGRAM, J; HELLMERS, R; LAAKE, D; MATTHEWS, Js; LI, K; NAVIAUX, Jc; NAVIAUX, Rk; ADAMS, Rl; COLEMAN, Dm; QUIG, Dw. Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder-A Randomized, Controlled 12-Month Trial. Nutrients, v. 10, n. 3, p. 1-43, 2018. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872787/pdf/nutrients-10-00369.pdf. Acesso em: 05 de out. de 2022.
ARABA, B; MARRAFA, C. Short-term aripiprazole therapy for autismspectrum disorderAripiprazole for autism spectrum disorders (ASD). Journal of Paediatrics and Child Health, v. 54, n. 12, p. 1389-1391. 2018. Disponível em: https://onlinelibrary.wiley.com/doi/10.1111/jpc.14268. Acesso em: 15 de dez. de 2022.
Autism Treatment Evaluation Checklist (ATEC). Disponível em: https://www.autism.org/autism-treatment-evaluation-checklist. Acesso em: 09 de out. 2022.
BENT, S; HENDREN, Rl; ZANDI, T; LAW, K; CHOI, J-e; WIDJAJA, F; KALB, L; NESTLE, J; LAW, P. Internet-Based, Randomized Controlled Trial of Omega-3 Fatty Acids for Hyperactivity in Autism. Journal of the American Academy of Child and Adolescent Psychiatry, v. 53, n. 6, p. 658-666. 2014. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076340/pdf/nihms587642.pdf. Acesso em: 06 de nov. de 2022.
BORGES, Bka; FONSECA, Bsl; SILVA, Jf; COSTA, Vrf; SOARES, Wd. Farmacoterapia em crianças e adolescentes portadores de Transtorno do Espectro Autista - TEA. Revista Bionorte, v. 8, n. 2, p. 11-21. 2019. Disponível em: https://www.revistabionorte.com.br/arquivos_up/artigos/a155.pdf. Acesso em 02 de out. de 2022.
BRASIL. Ministério da saúde. Conitec. Protocolo Clínico e Diretrizes Terapêuticas do Comportamento Agressivo no Transtorno do Espectro do Autismo. Brasília-DF, 2021. 104 p.
CIPOLLA, Cm; LODHI, Ij. Peroxisomal Dysfunction in Age-Related Diseases. Trends in Endocrinology and Metabolism, v. 28, n. 4, p.: 297–308, 2017. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366081/pdf/nihms837298.pdf. Acesso em: 12 de out. de 2022.
CORDIOLI, Av; KIELING, C; SILVA, Ctb; PASSOS, Ic; BARCELOS, Mt. Manual Diagnóstico e Estatístico de Transtornos Mentais: DSM-V. 5. ed. Porto Alegre: Artmed; 2014. 848 p.
CUCINOTTA, F; RICCIARDELLO, A; TURRIZIANI, L; MANCINI, A; KELLER, R; SACCO, R; PERSICO, Am. Efficacy and Safety of Q10 Ubiquinol With Vitamins B and E in Neurodevelopmental Disorders: A Retrospective Chart Review. Frontiers in Psychiatry, v. 13, p. 1-10. 2022. Disponível em: https://www.frontiersin.org/articles/10.3389/fpsyt.2022.829516/full. Acesso em: 16 de dez. de 2022.
CUCIUREANU Md; VINK, R. Magnesium in the Central Nervous System. Magnesium and stress. Adelaide (AU): University of Adelaide Press; 2011. 46 p. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK507250/. Acesso em 18 de dez. de 2022.
DEVANE, Cl; CHARLES, Jm; ABRAMSON, Rk; WILLIAMS, Je; CARPENTER, La; RAVEN, S; GWYNETTE, F; STUCK, Ca; GEESEY, Me; BRADLEY, C; DONOVAN, Jl; HALL, Ag; SHERK, St; POWERS, Nr; SPRATT, E; KINSMAN, A; KRUESI, Mj; JR, Jeb. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial. Pharmacotherapy, v 39, n 6, p. 626-635. 2019. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555676/pdf/nihms-1028157.pdf. Acesso em 15 de nov. de 2022.
DOAEI, S; BOURBOUR, F; TEYMOORI, Z; JAFARI, F; KALANTARI, N; TORKI, Sa; ASHOORI, N; GORGANI, Sn; GHOLAMALIZADEH, M. The effect of omega-3 fatty acids supplementation on social and behavioral disorders of children with autism: a randomized clinical trial. Pediatric Endocrinology Diabetes and Metabolism, v. 25, n. 1, p. 12–18. 2021. Disponível em: https://www.termedia.pl/The-effect-of-omega-3-fatty-acids-supplementation-on-social-and-behavioral-disorders-of-children-with-autism-a-randomized-clinical-trial,138,42737,1,1.html. Acesso em: 10 de out. de 2022.
DOMINIAK, A; WILKANIEC, A; JĘŚKO, H; CZAPSKI, A; LENKIEWICZ, Am; KUREK, E; WROCZYŃSKI, P; ADAMCZYK, A. Selol, an organic selenium donor, prevents lipopolysaccharide-induced oxidative stress and inflammatory reaction in the rat brain. Neurochemistry International, v 108, p. 66-77. 2017. Disponível em: https://www.sciencedirect.com/science/article/abs/pii/S019701861630331X?via%3Dihub. Acesso em: 26 de out. de 2022.
GEIER, Da; KERN, Jk; DAVIS, G; KING, Pg; ADAMS, Jb; YOUNG, Jl; GEIER, Mr. A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Medical Science Monitor, v. 17, n. 6, p. 15-23. 2011. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539542/pdf/medscimonit-17-6-pi15.pdf. Acesso em: 21 de nov. de 2022.
GOGOU, M; KOLIOS, G. The effect of dietary supplements on clinical aspects of autism spectrum disorder: A systematic review of the literature. Brain & Development, v 39, n 8, p. 656–664. 2017. Disponível em: https://www.brainanddevelopment.com/article/S0387-7604(17)30113-4/fulltext. Acesso em: 04 de dez. de 2022.
KEIM, As; JUDE, A; SMITH, K; KHAN, Aq; COURY, Dl; RAUSCH, J; UDAIPURIA, S; NORRIS, M; BARTRAM, Lr; NARAYANAN, A; ROGERS, Lk. Randomized Controlled Trial of Omega-3 and -6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum. Journal of Autism and Developmental, v. 52, p. 5342–5355. 2022. Disponível em: https://link.springer.com/content/pdf/10.1007/s10803-021-05396-9.pdf?pdf=button. Acesso em 04 de dez. de 2022.
KEPKA, A; OCHOCI ´NSKA, A; CHOJNOWSKA, S; BORZYM-KLUCZYK, M; SKORUPA, E; KNA´S, M; WASZKIEWICZ, N. Potential Role of L-Carnitine in Autism Spectrum Disorder. Journal of Clinical Medicine, v. 10, p. 1-26. 2021. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000371/pdf/jcm-10-01202.pdf. Acesso em: 21 de nov. de 2022.
KĘPKA, A; OCHOCIŃSKA, A; CHOJNOWSKA, S; BORZYM-KLUCZYK, M;
KHANNA, R; JARIWALA, K. Awareness and knowledge of autism among pharmacists. Research in Social and Administrative Pharmacy, v. 8, n. 5, p. 464-471, 2012. Disponível em: https://www.sciencedirect.com/journal/research-in-social-and-administrative-pharmacy/vol/8/issue/5. Acesso em: 02 de out. de 2022.
KIM, S.-J; SHONKA, S; FRENCH, Wp; STRICKLAND, J; MILLER, L; STEIN, Ma. Dose-response effects of long-acting liquid methylphenidate in children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): a pilot study. Journal of Autism and Developmental Disorders, v. 47, n. 8, p. 2307-2313. 2017. Disponível em: https://link.springer.com/article/10.1007%2Fs10803-017-3125-1. Acesso em: 25 de nov. de 2022.
KIRKLAND, Ae; SARLO, Gl; HOLTON, Kf. The Role of Magnesium in Neurological Disorders. Nutrients, v. 10, p. 1-23. 2018. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024559/pdf/nutrients-10-00730.pdf. Acesso em: 17 de dez. de 2022.
KUWABARA, H; YAMASSUE, H; KOIKE, S; INOUE, H; KAWAKUBO, Y; KURODA, M; TAKANO, Y; IWASHIRO, N; NATSUBORI, T; AOKI, Y; KANO, Y; KASAI, K. Altered Metabolites in the Plasma of Autism Spectrum Disorder: A Capillary Electrophoresis Time-of-Flight Mass Spectroscopy Study. Plos One, v. 8, n. 9, p. 1-8. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776798/pdf/pone.0073814.pdf. Acesso em: 20 de dez. de 2022.
LEE, T-m; LEE, K-m; LEE, C-y; LEE, H-c; TAM, K-w; LO, E-w. Effectiveness of N-acetylcysteine in autism spectrum disorders: A meta-analysis of randomized controlled trials. Australian & New Zealand Journal of Psychiatry, v. 55, n. 2, p. 1-11. 2021. Disponível em: https://journals.sagepub.com/doi/pdf/10.1177/0004867420952540. Acesso em 14 de dez. de 2022.
LIU, J; LIU, X; XIONG, X-Q; YANG, T; CUI, T; HOU, N-L; LAI, X; LIU, S; GUO, M; LIANG, X-H; CHENG, Q; CHEN, J; LI, T-Y. Effect of vitamin A supplementation on gut microbiota in children with autism spectrum disorders - a pilot study. BMC Microbiology, v 17, p. 1-14. 2017. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610466/pdf/12866_2017_Article_1096.pdf. Acesso em: 05 de dez. de 2022.
LIU, X; LIN, J; ZHANG, H; KHAN, Nu; ZHANG, J; TANG, X; CAO, X; SHEN, L. Oxidative Stress in Autism Spectrum Disorder—Current Progress of Mechanisms and Biomarkers. Frontiers in Psychiatry, v. 13, p. 1-20. 2022. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921264/pdf/fpsyt-13-813304.pdf. Acesso em: 20 de nov. de 2022.
LOPES Damg. Atenção farmacêutica e consultórios farmacêuticos. Revista acadêmica Faculdades Oswaldo Cruz, n. 16 p. 1-9. 2017. Disponível em: https://oswaldocruz.br/revista_academica/content/pdf/Edicao_16_LOPES_Denise_Aparecida_Moreira_Gollner.pdf. Acesso em: 09 jun 2022.
MAHAPATRA, S; KHOKHLOVICH, E; MARTINEZ, S; KANNEL, B; EDELSON, Sm; VYSHEDSKIY, A. Longitudinal Epidemiological Study of Autism Subgroups Using Autism Treatment Evaluation Checklist (ATEC) Score. Journal of Autism and Developmental Disorders, v. 50, n. 5, p. 1497–1508. 2018. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211200/pdf/10803_2018_Article_3699.pdf. Acesso em: 20 de dez. de 2022.
MALAGUARNERA, M; CAULI, O. Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies. Molecules, v 24, p. 1-10. 2019. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930613/pdf/molecules-24-04262.pdf. Acesso em: 12 de out. de 2022.
MARTÍNEZ-GONZÁLEZ, Ae; ANDREO-MARTÍNEZ, P. Prebiotics, probiotics and fecal microbiota transplantation in autism: A systematic review. Revista de Psiquiatría y Salud Mental (English Edition), v 13, n 3, p. 150-164. Disponível em: https://www.sciencedirect.com/science/article/abs/pii/S1888989120300719. Acesso em: 03 de dez. de 2022.
MAZAHERY, H; CONLON, Ca; BECK, Kl; MUGRIDGE, O; KRUGER, Mc; STONEHOUSE, W; JR, Cac; MEYER, Bj; TSANG, B; JONES, B; HURST, Prv. A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder. Journal of Autism and Developmental Disorders, v 49, p. 1778-1794. 2019. Disponível em: https://link.springer.com/content/pdf/10.1007/s10803-018-3860-y.pdf?pdf=button. Acesso em: 13 de dez. de 2022.
MAZAHERY, H; JR, Cac; CONLON, C; BECK, Kl; KRUGER, Mc; HURSY, Prv. Vitamin D and Autism Spectrum Disorder: A Literature Review. Nutrients, v. 8, n. 4, p. 1-35. 2016. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848704/pdf/nutrients-08-00236.pdf. Acesso em: 18 de out. de 2022.
MOUSAVINEJAD, E; GHAFFARI, Ma; RIAHI, F; HAJMOHAMMADI, M; TYZNOBEYK, Z; MOUSAVINEJAD, M. Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders. Psychiatry Research, v. 265, p. 62-69. 2018. Disponível em: https://www.sciencedirect.com/science/article/abs/pii/S0165178117317869?via%3Dihub. Acesso em 20 de nov. de 2022.
NAMVARPOUR, Z; NASEHI, M; AMINI, A; ZARRINDAST, Mr. Protective role of alpha-lipoic acid in impairments of social and stereotyped behaviors induced by early postnatal administration of thimerosal in male rat. Neurotoxicology and Teratology, v. 67, p. 1-9. 2018. Disponível em: https://www.sciencedirect.com/science/article/abs/pii/S0892036217300867?via%3Dihub. Acesso em: 21 de nov. de 2022.
PANGRAZZI, L; BALASCO, L; BOZZI, Y. Natural Antioxidants: A Novel Therapeutic Approach to Autism Spectrum Disorders? Antioxidants, v. 9, p. 1-17. 2020. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761361/pdf/antioxidants-09-01186.pdf. Acesso em: 15 de dez. de 2022.
PEARSON, Da; SANTOS, Cw; AMAN, Mg; ARNOLD, Le; CASAT, Cd; MANSOUR, R; LANE, Dm; LOVELAND, Ka; BUKSTEIN, Og; JERGER, Sw; FACTOR, P; VANWOERDEN, S; PEREZ, E; CLEVELAND, La. Effects of Extended Release Methylphenidate Treatment on Ratings of Attention-Deficit/Hyperactivity Disorder (ADHD) and Associated Behavior in Children with Autism Spectrum Disorders and ADHD Symptoms. Journal of Child and Adolescent Psychopharmacoly, v. 23, n. 5, p. 337-351. 2013. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689935/pdf/cap.2012.0096.pdf. Acesso em: 21 de dez. de 2022.
PISACANE, R; SALVO, M. Pharmaceutical update on autism and its management. U.S. Pharmacist, v. 38, n. 1, p. 19-22, 2013. Disponível em: https://www.uspharmacist.com/article/pharmacist-update-on-autism-and-itsmanagement. Acesso em: 10 de out. de 2022.
ROSE, S; BENNURI, Sc; MURRAY Kf; BUIE, T; WINTER, H; FRYE, Re. Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded case-control study. Plos one, v. 12, n. 10, p. 1-19, 2017. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640251/pdf/pone.0186377.pdf. Acesso em: 02 de out. 2022.
SHARMA, Sr; GONDA, X; TARAZI, Fi. Autism Spectrum Disorder: Classification, diagnosis and therapy. Pharmacology & Therapeutics, v. 190, p. 91-104, 2018. Disponível em: https://www.sciencedirect.com/journal/pharmacology-and-therapeutics/vol/190/suppl/C. Acesso em: 30 de set. de 2022.
SKALNY, Av; SIMASHKOVA, Nv; SKALNAYA, Aa; KLYUSHNIK, Tp; ZHEGALOVA, Iv; GRABEKLIS, Ar; SKALNAYA, Mg; TINKOV, Aa. Trace element levels are associated with neuroinflammatory markers in children with autistic spectrum disorder. Journal of Trace Elements in Medicine and Biology, v. 50, p. 622–628. 2018. Disponível em: https://www.sciencedirect.com/science/article/abs/pii/S0946672X18300324?via%3Dihub. Acesso em: 17 de dez. de 2021.
SKORUPA, E; KNAŚ, M; WASZKIEWICZ, N. Potential Role of L-Carnitine in Autism Spectrum Disorder. Journal of Clinical Medicine, v 10, p. 1-26. 2021. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000371/pdf/jcm-10-01202.pdf. Acesso em: 12 de out. de 2022.
STEPANOVA, E; DOWLING, S; PHELPS, M; FINDLING, Rl. Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents. Dialogues in Clinical Neuroscience, v. 19, n. 4, p. 395-402. 2017. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789216/pdf/DialoguesClinNeurosci-19-395.pdf. Acesso em: 04 de dez. de 2022.
WU, H; ZHAO, G; LIU, S; ZHANG, Q; WANG, P; CAO, Y; WU, L. Supplementation with selenium attenuates autism-like behaviors and improves oxidative stress, inflammation and related gene expression in an autism disease model. The Journal of Nutritional Biochemistry, v. 107, p. 1-13. 2022. Disponível em: https://reader.elsevier.com/reader/sd/pii/S095528632200105X?token=A3FE74FCA03076092E12E19EDD45946E5280F4D5A91C292594D53DBD7409CF7EF0298FB9271BB8FE6B60BCA1513BAE99&originRegion=us-east-1&originCreation=20230106191515. Acesso em: 14 de dez. de 2022.